AGP Executive Report
Last update: 10 hours agoItaly Health & Care: Italy-based biotech Aptadir Therapeutics raised $45.4M (€40M) seed funding to advance RNA-based treatments for genetic disorders, led by a program for Fragile X syndrome, aiming to move from preclinical work toward clinical testing. Duchenne Research: Italfarmaco reported new long-term Phase 3 EPIDYS data suggesting givinostat (Duvyzat®) may help preserve upper-limb function in boys with Duchenne muscular dystrophy, presented at the World Muscle Society Congress in Milan. Public Health Alerts: West Nile virus is being flagged as a potentially lethal outbreak across 16 European countries, with recent case and death reports in several nations—mosquito prevention is the key message. Cardiovascular Risk: A major study links greater blood pressure variability to a much higher risk of death and stroke, reinforcing the need for consistent monitoring. Safety & Medicines: The US indicted two Indian nationals over alleged counterfeit Ozempic smuggling and sales, including claims the scheme continued even after FDA warnings. Italy-Linked Incident: After a bus crash in Bavaria, most Filipino passengers have been discharged and arrangements are underway for repatriation of the deceased, with some still hospitalized.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
